Category: Arthritis
Global Arthritis
-
Bone Densitometer Market by Type (DEXA, Peripheral), Application (Osteopenia & Osteoporosis, Cystic Fibrosis, CKD, Body Composition Measurement, Rheumatoid Arthritis), End User (Hospitals & Specialty Clinics, Diagnostic Centres) - Global Forecast to 2027
... used to measure the amount of calcium and other minerals in the bones. They are used primarily to detect osteopenia or osteoporosis, diseases in which the bone mineral density is low. The global bone densitometer ... Read More
-
Global Companion Animal Arthritis Market Size study, by Animal Type (Dogs, Cats, Others), by Animal Type (Dogs, Cats, Others) by Indication (Osteoarthritis, Other Arthritis) by Treatment (Medication, Supplements, Other Treatment) by Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, Online Stores, Others) and Regional Forecasts 2022-2028
... & Clinics, Retail Pharmacies, Online Stores, Others) and Regional Forecasts 2022-2028 Global Companion Animal Arthritis Market is valued approximately USD 2.9 billion in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
Global Non-steroidal Anti-inflammatory Drugs Market Size study, by Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Others) by Route of Administration (Oral, Topical, Others) by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)and Regional Forecasts 2022-2028.
... Non-steroidal Anti-inflammatory Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Nonsteroidal anti-inflammatory medications are ... Read More
-
Complementary and Alternative Medicine Market By Type (Medicines, Therapy), By Disease Indication (Diabetes, Cardiovascular, Neurology, Cancer, Arthritis, Others), By Distribution Channels (Direct Sales, Online Sales, Distance Correspondence): Global Opportunity Analysis and Industry Forecast, 2021-2031
... global complementary and alternative medicine market was valued at $101,995.95 million in 2021 and is projected to reach $437,864.92 million by 2031, registering a CAGR of 15.6% from 2022 to 2031 The term complementary and ... Read More
-
Global Missouri Medical Cannabis Market Size study, By Product Type (Flower, Oils & Tinctures), By Application (Cancer, Chronic Pain, Arthritis, Diabetes, AIDS, Others), and Regional Forecasts 2022-2028
... USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Missouri medical cannabis is also known as marijuana, which is any strain ... Read More
-
Morphine Market: Segmented: by application (Pain Management, Cancer Pain, Neuropathic Pain, Osteoarthritis Pain, Other Pain Management, Diarrhea Suppressant, Cold and Cough Suppressant); by Routine (Oral, Injectables); , And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
... Share & Trends For 2019–2020 And Forecasts To 2031 Morphine Market to surpass USD 57 billion by 2031 from USD 28 billion in 2021 at a CAGR of 7.3% in the coming years, i.e., 2021-31. ... Read More
-
Autoinjectors Global Market Report 2022 Including: 1) By Type: Disposable Autoinjectors; Reusable Autoinjectors 2) By Therapy: Rheumatoid Arthritis; Multiple Sclerosis; Diabetes; Anaphylaxis; Other Therapies 3) By Route Of Administration: Subcutaneous; Intramuscular 4) By Distribution Channel: Online Retailer; Pharmacy 5) By End User: Home Care Settings; Hospitals And Clinics; Other End Users Covering: AbbVie; Mylan; Eli Lilly and Company; Amgen; Becton, Dickinson and Company; Johnson & Johnson; Teva Pharmaceutical; Merck; Pfizer; Bayer; Biogen; AstraZeneca
... report focuses on autoinjectors market which is experiencing strong growth. The report gives a guide to the autoinjectors market which will be shaping and changing our lives over the next ten years and beyond, including ... Read More
-
Global Osteoarthritis Drugs Market - 2022-2029
... of arthritis, affecting millions of people worldwide. It is a degenerative disease that worsens over time and occurs when the protective cartilage on the person’s bones wears down. The disorder generally affects joints in the ... Read More
-
Chronic Pain Market, by Drug (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, Others), by Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia and Others), by Appli
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Chronic pain ... Read More
-
Axial Spondyloarthritis Market - A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products, Indication, and Country - Analysis and Forecast, 2022-2032
... global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032. The growth in the global axial ... Read More
-
Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)
... spanning 2022 to 2026. Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, ... Read More
-
2022 Global: Osteoarthritis Therapeutics - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
-
2022 Global Forecast for Osteoarthritis Therapeutics (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Global Meloxicam Market Size study, by Diseases (Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Others) by Drug Type (Generic, Branded) by Population Type (Adult, Children) by Dosage (Oral, Parenteral, transdermal, Others) by Dose Strength (7.5mg, 15mg, Others) by End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others) by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2022-2028
... Others) by End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others) by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2022-2028Global Meloxicam Market is valued approximately USD XX billion in 2021 ... Read More
-
Global Antisynthetase Syndrome Market Size study, by Symptoms (Muscle Disease, Interstitial Lung Disease, Arthritis) by Gender (Male, Female) by Diagnosis (Clinical Testing, Workup) by Treatment (Medication, Physical Therapy) and Regional Forecasts 2022-2028
... Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Antisynthetase Syndrome is a type of ... Read More
-
Global Osteoarthritis Gene Therapy Market Size study, by Site of Injection (Synovium, Cartilage) by Vectors (Non-viral, Retrovirus, Lentivirus, Adenovirus, Adeno-associated virus (AAV), HSV) by end use industries (Hospitals and clinics, Orthopedic Centers, Assisted living Facilities, Nursing, Homes, Ambulatory Surgical Centers, Others) and Regional Forecasts 2021-2027
... Nursing, Homes, Ambulatory Surgical Centers, Others) and Regional Forecasts 2021-2027 Global Osteoarthritis Gene Therapy Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Osteoarthritis Therapeutics: Global Markets
... for different types of drugs and therapies used to treat osteoarthritis. Based on anatomy, the osteoarthritis therapeutics market is segmented into knee osteoarthritis, hip osteoarthritis, others (shoulder, hand and small joint osteoarthritis). Based on drug ... Read More
-
Global Cold Laser Therapy Market Size study, by Product (Continuous Laser Devices, Pulse Laser Devices, Combination Laser Devices), by Technology (Single Wavelength Cold Laser Therapy Devices, Multiple Wavelength Cold Laser Therapy Devices), by Application (Pain Management, Arthritis, Wound Healing, Nerve Regeneration, Dermatology, Musculoskeletal, Others) and Regional Forecasts 2021-2027
... Management, Arthritis, Wound Healing, Nerve Regeneration, Dermatology, Musculoskeletal, Others) and Regional Forecasts 2021-2027 Global Cold Laser Therapy Market is valued at approximately USD 104 million in 2020 and is anticipated to grow with a healthy ... Read More
-
Rheumatoid Arthritis Drugs Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis
... that induces pain and inflammation in joints. It influences individuals of all ages; notwithstanding, the geriatric population is highly susceptible to developing this disorder. The symptoms of rheumatoid arthritis embrace pain, stiffness, tenderness, and swelling ... Read More
-
Ankylosing Spondylitis Market by Drug Class (NSAIDs, TNF Inhibitors and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021–2030
... $5,140.94 million in 2020, and is projected to reach $8,110.59 million by 2030, registering a CAGR of 4.6%% from 2021 to 2030. Ankylosing spondylitis (AS) is a rare type of arthritis that causes pain and ... Read More
-
Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry
... are characterized by chronic pain, with some of the most common conditions being osteoarthritis (OA) and rheumatoid arthritis (RA), and it is estimated that about one in four adults in America are diagnosed with a ... Read More
Research Assistance
